LARGE anticorps (AA 35-142)
Aperçu rapide pour LARGE anticorps (AA 35-142) (ABIN5541530)
Antigène
Voir toutes LARGE AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 35-142
-
Specificité
- This antibody recognizes human LARGE1, a glycosyltransferase localizing mainly to the Golgi apparatus. Crossreactivity with LARGE2 was not determined.
-
Purification
- Protein-A affinity chromatography (> 95% pure by SDS-PAGE)
-
Immunogène
- Recombinant fragment of human LARGE1 (amino acids 35-142)
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- Flow cytometry. Western blot.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 95 % pure by SDS-PAGE) Buffer System: Phosphate buffered saline (PBS) Preservatives: 15 mM sodium azide, approx. pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store undiluted at 2-8°C. DO NOT FREEZE! Shelf life: one year from despatch.
-
Date de péremption
- 12 months
-
-
- LARGE (Like-Glycosyltransferase (LARGE))
-
Autre désignation
- large
-
Sujet
- LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.
-
UniProt
- O95461
Antigène
-